| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |